US Stock MarketDetailed Quotes

LSB LakeShore Biopharma

Watchlist

0.590
0.0000.00%

Trading Jul 1 16:00 ET

111.19MMarket Cap-1409P/E (TTM)

LakeShore Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

(FY)Mar 31, 2022

(FY)Mar 31, 2021

Total revenue

-50.11%96.82M

-14.21%176.27M

36.63%687.2M

194.06M

205.48M

95.69%502.95M

257.02M

Operating revenue

-50.11%96.82M

-14.21%176.27M

36.63%687.2M

--194.06M

--205.48M

95.69%502.95M

--257.02M

Cost of revenue

-58.87%17.51M

-32.18%34.68M

31.00%153.36M

42.57M

51.13M

96.23%117.07M

59.66M

Gross profit

-47.65%79.31M

-8.26%141.59M

38.34%533.84M

151.49M

154.34M

95.52%385.88M

197.36M

Operating expense

32.72%179.36M

26.55%210.17M

34.31%647.15M

135.14M

166.08M

50.72%481.82M

319.68M

Selling and administrative expenses

10.10%114.3M

15.63%111.01M

22.20%333.32M

--103.81M

--96M

30.93%272.77M

--208.33M

-Selling and marketing expense

-1.54%78.51M

12.34%79.2M

51.80%251.56M

--79.74M

--70.49M

138.66%165.72M

--69.44M

-General and administrative expense

48.67%35.8M

24.71%31.81M

-23.62%81.76M

--24.08M

--25.51M

-22.93%107.05M

--138.89M

Research and development costs

45.99%78.21M

43.18%100.64M

50.88%318.7M

--53.57M

--70.29M

123.78%211.22M

--94.39M

Depreciation amortization depletion

----

5.56%6.33M

----

-36.79%6M

--9.49M

-Depreciation and amortization

----

5.56%6.33M

----

-36.79%6M

--9.49M

Provision for doubtful accounts

----

70.29%8.66M

----

-27.38%5.08M

--7M

Other taxes

----

21.51%6.54M

----

34.36%5.38M

--4M

Other operating expenses

40.87%-13.15M

-601.90%-1.47M

-41.71%-26.4M

---22.25M

---210K

-427.61%-18.63M

---3.53M

Operating profit

-711.84%-100.05M

-484.26%-68.58M

-18.11%-113.31M

16.35M

-11.74M

21.57%-95.94M

-122.32M

Net non-operating interest income expense

34.77%-4.94M

-8.85%-8.03M

-1,035.54%-30.86M

-7.57M

-7.38M

90.85%-2.72M

-29.69M

Non-operating interest expense

-12.02%6.9M

8.85%8.03M

1,035.54%30.86M

--7.84M

--7.38M

-90.85%2.72M

--29.69M

Other net income (expense)

37.32%-223.62K

4,809.09%6.48M

92.62%-178.09K

-356.74K

132K

89.22%-2.41M

-22.36M

Gain on sale of security

--158.31K

--6.69M

--21.36K

----

Other non- operating income (expenses)

-7.06%-381.93K

-261.36%-213K

91.73%-199.45K

---356.74K

--132K

89.22%-2.41M

---22.36M

Income before tax

-1,349.40%-105.22M

-269.46%-70.13M

-42.82%-144.35M

8.42M

-18.98M

42.04%-101.07M

-174.37M

Income tax

-405.34%-234.35K

-195.75%-586K

-77.04%1.13M

-46.38K

612K

-71.71%4.94M

17.45M

Net income

-1,339.79%-104.98M

-254.93%-69.54M

-37.24%-145.48M

8.47M

-19.59M

44.74%-106M

-191.83M

Net income continuous Operations

-1,339.79%-104.98M

-254.93%-69.54M

-37.24%-145.48M

--8.47M

---19.59M

44.74%-106M

---191.83M

Minority interest income

Net income attributable to the parent company

-1,339.79%-104.98M

-254.93%-69.54M

-37.24%-145.48M

8.47M

-19.59M

44.74%-106M

-191.83M

Preferred stock dividends

Other preferred stock dividends

5.61%137.99M

37.61M

34.47M

686.63%130.66M

16.61M

Net income attributable to common stockholders

-260.23%-104.98M

-28.62%-69.54M

-19.78%-283.47M

-29.14M

-54.07M

-13.54%-236.67M

-208.44M

Basic earnings per share

-258.26%-1.1327

-27.40%-0.7473

-18.64%-3.0462

-0.3162

-0.5866

-13.54%-2.5676

-2.2613

Diluted earnings per share

-258.26%-1.1327

-27.40%-0.7473

-18.64%-3.0462

-0.3162

-0.5866

-13.54%-2.5676

-2.2613

Dividend per share

Currency Unit

CNY

Audit Opinions

Unqualified Opinion

	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022	(FY)Mar 31, 2022	(FY)Mar 31, 2021
Total revenue	-50.11%96.82M	-14.21%176.27M	36.63%687.2M	194.06M	205.48M	95.69%502.95M	257.02M
Operating revenue	-50.11%96.82M	-14.21%176.27M	36.63%687.2M	--194.06M	--205.48M	95.69%502.95M	--257.02M
Cost of revenue	-58.87%17.51M	-32.18%34.68M	31.00%153.36M	42.57M	51.13M	96.23%117.07M	59.66M
Gross profit	-47.65%79.31M	-8.26%141.59M	38.34%533.84M	151.49M	154.34M	95.52%385.88M	197.36M
Operating expense	32.72%179.36M	26.55%210.17M	34.31%647.15M	135.14M	166.08M	50.72%481.82M	319.68M
Selling and administrative expenses	10.10%114.3M	15.63%111.01M	22.20%333.32M	--103.81M	--96M	30.93%272.77M	--208.33M
-Selling and marketing expense	-1.54%78.51M	12.34%79.2M	51.80%251.56M	--79.74M	--70.49M	138.66%165.72M	--69.44M
-General and administrative expense	48.67%35.8M	24.71%31.81M	-23.62%81.76M	--24.08M	--25.51M	-22.93%107.05M	--138.89M
Research and development costs	45.99%78.21M	43.18%100.64M	50.88%318.7M	--53.57M	--70.29M	123.78%211.22M	--94.39M
Depreciation amortization depletion	----	----	5.56%6.33M	----	----	-36.79%6M	--9.49M
-Depreciation and amortization	----	----	5.56%6.33M	----	----	-36.79%6M	--9.49M
Provision for doubtful accounts	----	----	70.29%8.66M	----	----	-27.38%5.08M	--7M
Other taxes	----	----	21.51%6.54M	----	----	34.36%5.38M	--4M
Other operating expenses	40.87%-13.15M	-601.90%-1.47M	-41.71%-26.4M	---22.25M	---210K	-427.61%-18.63M	---3.53M
Operating profit	-711.84%-100.05M	-484.26%-68.58M	-18.11%-113.31M	16.35M	-11.74M	21.57%-95.94M	-122.32M
Net non-operating interest income expense	34.77%-4.94M	-8.85%-8.03M	-1,035.54%-30.86M	-7.57M	-7.38M	90.85%-2.72M	-29.69M
Non-operating interest expense	-12.02%6.9M	8.85%8.03M	1,035.54%30.86M	--7.84M	--7.38M	-90.85%2.72M	--29.69M
Other net income (expense)	37.32%-223.62K	4,809.09%6.48M	92.62%-178.09K	-356.74K	132K	89.22%-2.41M	-22.36M
Gain on sale of security	--158.31K	--6.69M	--21.36K	----	----	----	----
Other non- operating income (expenses)	-7.06%-381.93K	-261.36%-213K	91.73%-199.45K	---356.74K	--132K	89.22%-2.41M	---22.36M
Income before tax	-1,349.40%-105.22M	-269.46%-70.13M	-42.82%-144.35M	8.42M	-18.98M	42.04%-101.07M	-174.37M
Income tax	-405.34%-234.35K	-195.75%-586K	-77.04%1.13M	-46.38K	612K	-71.71%4.94M	17.45M
Net income	-1,339.79%-104.98M	-254.93%-69.54M	-37.24%-145.48M	8.47M	-19.59M	44.74%-106M	-191.83M
Net income continuous Operations	-1,339.79%-104.98M	-254.93%-69.54M	-37.24%-145.48M	--8.47M	---19.59M	44.74%-106M	---191.83M
Minority interest income
Net income attributable to the parent company	-1,339.79%-104.98M	-254.93%-69.54M	-37.24%-145.48M	8.47M	-19.59M	44.74%-106M	-191.83M
Preferred stock dividends
Other preferred stock dividends	0	0	5.61%137.99M	37.61M	34.47M	686.63%130.66M	16.61M
Net income attributable to common stockholders	-260.23%-104.98M	-28.62%-69.54M	-19.78%-283.47M	-29.14M	-54.07M	-13.54%-236.67M	-208.44M
Basic earnings per share	-258.26%-1.1327	-27.40%-0.7473	-18.64%-3.0462	-0.3162	-0.5866	-13.54%-2.5676	-2.2613
Diluted earnings per share	-258.26%-1.1327	-27.40%-0.7473	-18.64%-3.0462	-0.3162	-0.5866	-13.54%-2.5676	-2.2613
Dividend per share
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall